Axsome Therapeutics AXSM
NASDAQ AXSM
$179.25 -2.82 (-1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Axsome Therapeutics (AXSM) reported Depreciation & Amortization (CF) of $1.16 million for Q2 2026, up 115.1% from $537,000 a year earlier and up 70.1% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Axsome Therapeutics' Depreciation & Amortization (CF) came in at $3.07 million, up 90.7% year-over-year; for FY2025, it came in at $2.19 million, up 111.4% from FY2024.

  • Depreciation & Amortization (CF) has increased for five consecutive years, with a five-year compound annual growth rate of 146.8% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.03 million in FY2024 (+125.3%), $459,000 in FY2023 (+74.5%), $263,000 in FY2022 (+246.1%) and $76,000 in FY2021 (+218.5%).
  • The Q2 2026 figure ranks as the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2015.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last 23 quarters, with growth averaging 120.4% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Depreciation & Amortization (CF) ranged from 46.7% (Q1 2024) to 587.2% (Q2 2022).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $679,000 (Q1 2026), $553,000 (Q4 2025) and $684,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Axsome Therapeutics 9.52 Bn 8.25 Bn 204.81 Mn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.16 Mn
Mar 31, 2026 679,000.00
Dec 31, 2025 553,000.00
Sep 30, 2025 684,000.00
Jun 30, 2025 537,000.00
Mar 31, 2025 412,000.00
Dec 31, 2024 337,000.00
Sep 30, 2024 324,000.00
Jun 30, 2024 263,000.00
Mar 31, 2024 132,000.00
Dec 31, 2023 133,000.00
Sep 30, 2023 136,000.00
Jun 30, 2023 100,000.00
Mar 31, 2023 90,000.00
Dec 31, 2022 85,000.00
Sep 30, 2022 74,000.00
Jun 30, 2022 67,000.00
Mar 31, 2022 37,000.00
Dec 31, 2021 30,695.00
Sep 30, 2021 27,230.00
API Access

Axsome Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AXSM&period=max&api_key=YOUR_API_KEY